静脉闭塞性疾病：当前管理的最新进展 - Suppr

Suppr

超能文献

Venous occlusive disease: the latest in current management.

作者信息

Ai Everett, Yang Sam S

机构信息

California Pacific Medical Center, and Westcoast Retina Medical Group, USA.

出版信息

Retina. 2006 Jul-Aug;26(6 Suppl):S63-4. doi: 10.1097/01.iae.0000236461.31264.c6.

DOI:10.1097/01.iae.0000236461.31264.c6

PMID:16832302

Abstract

摘要

相似文献

Venous occlusive disease: the latest in current management.

Retina. 2006 Jul-Aug;26(6 Suppl):S63-4. doi: 10.1097/01.iae.0000236461.31264.c6.

Venous occlusive disease: management 25 years ago.

Retina. 2006 Jul-Aug;26(6 Suppl):S51-62. doi: 10.1097/01.iae.0000236458.85522.96.

Venous occlusive disease review.

Retina. 2007 Apr-May;27(4):514; author reply 514-7. doi: 10.1097/IAE.0b013e3180318fea.

[Retinal venous occlusion].

Rev Med Suisse Romande. 1996 Jan;116(1):31-5.

Diabetic retinopathy: the latest in current management.

Retina. 2006 Jul-Aug;26(6 Suppl):S71-9. doi: 10.1097/01.iae.0000236466.23640.c9.

Branch retinal vein occlusion: classification and treatment.

Ophthalmologica. 2009;223(5):298-305. doi: 10.1159/000213640. Epub 2009 Apr 16.

[News in management of retinal vein occlusion].

Oftalmologia. 2010;54(3):51-7.

Clinical practice. Retinal-vein occlusion.

N Engl J Med. 2010 Nov 25;363(22):2135-44. doi: 10.1056/NEJMcp1003934.

Retinal detachment surgery: the latest in current management.

Retina. 2006 Jul-Aug;26(6 Suppl):S28-33. doi: 10.1097/01.iae.0000236462.31264.1d.

Controversy in the management of retinal venous occlusive disease.

Int Ophthalmol Clin. 2004 Fall;44(4):85-102. doi: 10.1097/00004397-200404440-00008.

引用本文的文献

Comparison of anti-vascular endothelial growth factors, laser treatments and a combination of the both for treatment of central retinal vein occlusion.

Int J Ophthalmol. 2016 Mar 18;9(3):431-3. doi: 10.18240/ijo.2016.03.18. eCollection 2016.

Anti-vascular endothelial growth factor for macular oedema secondary to central retinal vein occlusion.

Cochrane Database Syst Rev. 2014 May 1;2014(5):CD007325. doi: 10.1002/14651858.CD007325.pub3.

Bevacizumab for CRVO Associated CME: Effect of Timing and Frequency of Injections on Final Visual Outcome.

J Ophthalmol. 2013;2013:974670. doi: 10.1155/2013/974670. Epub 2013 Dec 29.

Anti-vascular endothelial growth factor for macular edema secondary to central retinal vein occlusion.

Cochrane Database Syst Rev. 2010 Oct 6(10):CD007325. doi: 10.1002/14651858.CD007325.pub2.

SCORE Study report 3: study design and baseline characteristics.

Ophthalmology. 2009 Sep;116(9):1770-1777.e1. doi: 10.1016/j.ophtha.2009.03.022. Epub 2009 Jul 19.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Venous occlusive disease: the latest in current management.

Retina. 2006 Jul-Aug;26(6 Suppl):S63-4. doi: 10.1097/01.iae.0000236461.31264.c6.

Venous occlusive disease: management 25 years ago.

Retina. 2006 Jul-Aug;26(6 Suppl):S51-62. doi: 10.1097/01.iae.0000236458.85522.96.

Venous occlusive disease review.

Retina. 2007 Apr-May;27(4):514; author reply 514-7. doi: 10.1097/IAE.0b013e3180318fea.

[Retinal venous occlusion].

Rev Med Suisse Romande. 1996 Jan;116(1):31-5.

Diabetic retinopathy: the latest in current management.

Retina. 2006 Jul-Aug;26(6 Suppl):S71-9. doi: 10.1097/01.iae.0000236466.23640.c9.

Branch retinal vein occlusion: classification and treatment.

Ophthalmologica. 2009;223(5):298-305. doi: 10.1159/000213640. Epub 2009 Apr 16.

[News in management of retinal vein occlusion].

Oftalmologia. 2010;54(3):51-7.

Clinical practice. Retinal-vein occlusion.

N Engl J Med. 2010 Nov 25;363(22):2135-44. doi: 10.1056/NEJMcp1003934.

Retinal detachment surgery: the latest in current management.

Retina. 2006 Jul-Aug;26(6 Suppl):S28-33. doi: 10.1097/01.iae.0000236462.31264.1d.

Controversy in the management of retinal venous occlusive disease.

Int Ophthalmol Clin. 2004 Fall;44(4):85-102. doi: 10.1097/00004397-200404440-00008.

引用本文的文献

Comparison of anti-vascular endothelial growth factors, laser treatments and a combination of the both for treatment of central retinal vein occlusion.

Int J Ophthalmol. 2016 Mar 18;9(3):431-3. doi: 10.18240/ijo.2016.03.18. eCollection 2016.

Anti-vascular endothelial growth factor for macular oedema secondary to central retinal vein occlusion.

Cochrane Database Syst Rev. 2014 May 1;2014(5):CD007325. doi: 10.1002/14651858.CD007325.pub3.

Bevacizumab for CRVO Associated CME: Effect of Timing and Frequency of Injections on Final Visual Outcome.

J Ophthalmol. 2013;2013:974670. doi: 10.1155/2013/974670. Epub 2013 Dec 29.

Anti-vascular endothelial growth factor for macular edema secondary to central retinal vein occlusion.

Cochrane Database Syst Rev. 2010 Oct 6(10):CD007325. doi: 10.1002/14651858.CD007325.pub2.

SCORE Study report 3: study design and baseline characteristics.

Ophthalmology. 2009 Sep;116(9):1770-1777.e1. doi: 10.1016/j.ophtha.2009.03.022. Epub 2009 Jul 19.